Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpishengxue Tablet for renal anemia in non-dialysis chronic kidney disease
ChiCTR2100046549Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Jianpishengxue in anemia of chronic kidney disease (2 arms), sponsored by Tongji Hospital. Primary endpoints: Blood routine examination, Renal function and 7 more. Started May 2021; status: recruiting.
02
Drugs
Jianpishengxue
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR2100046549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046549.